These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32721475)

  • 1. MicroRNAs as regulators of VEGFA and NFE2L2 in cancer.
    Cuzziol CI; Castanhole-Nunes MMU; Pavarino ÉC; Goloni-Bertollo EM
    Gene; 2020 Oct; 759():144994. PubMed ID: 32721475
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Stuchi LP; Castanhole-Nunes MMU; Maniezzo-Stuchi N; Biselli-Chicote PM; Henrique T; Padovani Neto JA; de-Santi Neto D; Girol AP; Pavarino EC; Goloni-Bertollo EM
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32824922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of
    Cuzziol CI; Marzochi LL; Possebon VS; Kawasaki-Oyama RS; Mattos MF; Junior VS; Ferreira LAM; Pavarino ÉC; Castanhole-Nunes MMU; Goloni-Bertollo EM
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage.
    Aksenenko MB; Palkina NV; Sergeeva ON; Yu Sergeeva E; Kirichenko AK; Ruksha TG
    Int J Exp Pathol; 2019 Oct; 100(5-6):311-319. PubMed ID: 32043657
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Akdemir B; Nakajima Y; Inazawa J; Inoue J
    Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of NRF2-regulated miRNAs in human malignancies.
    Shah NM; Rushworth SA; Murray MY; Bowles KM; MacEwan DJ
    Oncotarget; 2013 Aug; 4(8):1130-42. PubMed ID: 24029073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
    Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
    Sun X; Zuo H; Liu C; Yang Y
    Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.
    Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J
    Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFE2L2/NRF2 Activity Is Linked to Mitochondria and AMP-Activated Protein Kinase Signaling in Cancers Through miR-181c/Mitochondria-Encoded Cytochrome c Oxidase Regulation.
    Jung KA; Lee S; Kwak MK
    Antioxid Redox Signal; 2017 Nov; 27(13):945-961. PubMed ID: 28383996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dual Roles of NRF2 in Cancer.
    Menegon S; Columbano A; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
    Cheng X; Ku CH; Siow RC
    Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
    Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
    Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma.
    Kanitz A; Imig J; Dziunycz PJ; Primorac A; Galgano A; Hofbauer GF; Gerber AP; Detmar M
    PLoS One; 2012; 7(11):e49568. PubMed ID: 23166713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of microRNA nuclear transport in human cancer.
    Melo SA; Esteller M
    Semin Cancer Biol; 2014 Aug; 27():46-51. PubMed ID: 24607282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor erythroid 2-like 2 (Nrf2) expression in end-stage liver disease.
    Kurzawski M; Dziedziejko V; Urasińska E; Post M; Wójcicki M; Miętkiewski J; Droździk M
    Environ Toxicol Pharmacol; 2012 Jul; 34(1):87-95. PubMed ID: 22459801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
    Siedlinski M; Postma DS; Boer JM; van der Steege G; Schouten JP; Smit HA; Boezen HM
    Respir Res; 2009 Aug; 10(1):73. PubMed ID: 19671143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells.
    Narasimhan M; Patel D; Vedpathak D; Rathinam M; Henderson G; Mahimainathan L
    PLoS One; 2012; 7(12):e51111. PubMed ID: 23236440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
    Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
    Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.